Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Contact
About us
Links
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Contact
About us
Links
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
About us
Contact
Links
About us
Contact
Links
Accordion Title
Accordion Content
more items +
Amid tariff agita, Wall Street is a bit more cautious than normal on second-quarter earnings
Why the government’s debt problem is your borrowing problem — but also your opportunity to save
Can media company spinoffs of brands like CNN and CNBC be good for investors? Here’s what history tells us.
‘I am getting very frustrated’: My mother’s adviser has not returned my calls. He manages $1 million. Is this normal?
These 3 corporate tax breaks in the Republican megabill look key for investors
Trump doubles steel tariffs to 50%, touts U.S. Steel-Nippon deal still short on details
S&P 500 scores best May since 1990, but stocks end month with fresh tariff worries
‘You are going to panic,’ Jamie Dimon tells regulators about what will happen when the bond market cracks
Regeneron dashes Wall Street’s hopes as COPD treatment trial suffers a failure
Marvell tried to ease a big investor concern, but the stock’s slump shows that doubts still linger
Tariff indigestion? Nope: Takeout and eating out still going strong in good sign for the economy.
Musk’s legacy at DOGE: A smaller Social Security Administration struggling under the weight of greater demand
Amid tariff agita, Wall Street is a bit more cautious than normal on second-quarter earnings
Why the government’s debt problem is your borrowing problem — but also your opportunity to save
Can media company spinoffs of brands like CNN and CNBC be good for investors? Here’s what history tells us.
‘I am getting very frustrated’: My mother’s adviser has not returned my calls. He manages $1 million. Is this normal?
These 3 corporate tax breaks in the Republican megabill look key for investors
Trump doubles steel tariffs to 50%, touts U.S. Steel-Nippon deal still short on details
S&P 500 scores best May since 1990, but stocks end month with fresh tariff worries
‘You are going to panic,’ Jamie Dimon tells regulators about what will happen when the bond market cracks
Regeneron dashes Wall Street’s hopes as COPD treatment trial suffers a failure
Marvell tried to ease a big investor concern, but the stock’s slump shows that doubts still linger
Tariff indigestion? Nope: Takeout and eating out still going strong in good sign for the economy.
Musk’s legacy at DOGE: A smaller Social Security Administration struggling under the weight of greater demand
Movers & Shakers: WD-40 shares climb after earnings top estimates, Iovance stock slumps on offering, and other stocks on the move
11-07-23
WD-40, Iovance Biotherapeutics and ADT are stocks on the move.
Share this on:
